Prognostic utility of Galectin-3 for recurrent cardiovascular events during long-term follow-up in patients with stable coronary heart disease: results of the KAROLA study

Documenti analoghi

• Increased plasma concentrations of soluble ST2 independently predict mortality but not cardiovascular events in stable coronary heart disease patients: 13-year follow-up of the KAROLA study
  di: Pfetsch, Vanessa, et al.
  Pubblicazione: (2017)
• Repeat measurements of high sensitivity troponins for the prediction of recurrent cardiovascular events in patients with established coronary heart disease: an analysis from the KAROLA study
  di: Jansen, Henning, et al.
  Pubblicazione: (2019)
• Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study
  Pubblicazione: (2013)
• Growth differentiation factor 15, its 12-month relative change, and risk of cardiovascular events and total mortality in patients with stable coronary heart disease: 10-year follow-up of the KAROLA Study
  di: Dallmeier Rojas, Dhayana Elizabeth, et al.
  Pubblicazione: (2016)
• Cardiac troponin T measured by a high sensitivity assay predicts recurrent cardiovascular events in stable coronary heart disease patients with 8-year follow-up
  Pubblicazione: (2012)